Lifeward (LFWD) Expected to Announce Quarterly Earnings on Friday

Lifeward (NASDAQ:LFWD) is projected to issue its Q3 2026 results before the market opens on Friday, November 13th. Analysts expect the company to post earnings of ($0.7850) per share and revenue of $7.24 million for the quarter. Investors are encouraged to explore the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Friday, November 20, 2026 at 8:30 AM ET.

Lifeward (NASDAQ:LFWD) last issued its earnings results on Saturday, August 15th. The company reported ($1.46) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.39) by ($0.07). Lifeward had a negative net margin of 141.28% and a negative return on equity of 235.86%. The company had revenue of $6.62 million during the quarter, compared to analyst estimates of $6.53 million. On average, analysts expect Lifeward to post ($0.44) EPS for the current fiscal year and ($1.84) EPS for the next fiscal year.

Lifeward Stock Performance

Shares of LFWD stock opened at $5.76 on Thursday. Lifeward has a one year low of $4.14 and a one year high of $9.61. The company’s 50-day simple moving average is $6.45 and its 200-day simple moving average is $6.88. The company has a quick ratio of 1.77, a current ratio of 2.33 and a debt-to-equity ratio of 0.70.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Citigroup restated a “buy” rating on shares of Lifeward in a research note on Friday, August 21st. Weiss Ratings upgraded Lifeward from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, October 9th. Zacks Research upgraded Lifeward from a “strong sell” rating to a “hold” rating in a report on Monday, July 27th. Finally, HC Wainwright reiterated a “buy” rating and issued a $10.00 price target on shares of Lifeward in a report on Friday, August 21st. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $10.00.

Lifeward Company Profile

Lifeward Ltd. (NASDAQ: LFWD) is a medical technology company focused on developing and commercializing wearable robotic systems designed to help people with mobility impairments stand, walk and participate in rehabilitation. The company was formerly known as ReWalk Robotics and adopted the Lifeward name in 2024. Lifeward’s principal product line is the ReWalk Personal Exoskeleton, a battery-powered wearable robotic device intended to enable individuals with lower-limb disabilities, including those resulting from spinal cord injury, to walk with the assistance of crutches or other support.